Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Fr | Stock Market Today: Dow Falls Ahead Of Inflation Survey; Gemini Space IPO Planned (Live Coverage) | ||
Fr | This Gold Stock Is Rising As The Shiny Metal Holds Above $3,600 | ||
Fr | How Reddit's Strong Results Fired Its Post-IPO Rally Back Up | ||
Fr | Cameco Stock Gets Boost From Analyst View; Earnings Growth Accelerates To Triple Digits | ||
Fr | Fed Meeting In Focus With FedEx, Lennar, Meta Due; Tesla Leads New Buys | ||
Fr | Arista Stock Rises After Touting AI Growth Outlook At Analyst Day | ||
Fr | Overcome Adversity By Viewing Setbacks As Opportunities To Grow | ||
Fr | Chess Champ Magnus Carlsen Focused On Details To Beat Competitors | ||
Fr | Nvidia Leads 13 Stocks, Including 2 That Hit Record Highs, Onto Best Stock Lists. Check Out The IBD 50, Sector Leaders Watchlist And More | ||
Fr | Dow Jones Index Rallies Above 46,000; Blackstone, Tesla Hit New Buy Points | ||
Do | Dow Jones Futures: Market Rally Gains Steam; Tesla Leads 5 Stocks Flashing Buy Signals | ||
Do | Adobe Stock Jumps As Creative Software Firm Beats Estimates | ||
Do | Why Klarna's Hot IPO Wasn't A Day-One Buy | ||
Do | IBD Live Q&A, Stock Lists For Thursday, Sept. 11, 2025 | ||
Do | Tesla Stock Flashes Buy Signals, Nears Breakout. It's Not About EVs. | ||
Do | Catch The Next Palantir, Nvidia Or IPO Gem. Here's How. | ||
Do | Micron Stock Leads The Memory Storage Group Higher As AI Demand Surges | ||
Do | Meta, Alphabet, OpenAI Face FTC Probe Over Safety Of Children Using AI Chatbots | ||
Do | Stock Of The Day: AI Play Quanta Services Flashes Buy Signal After Oracle Boom | ||
Do | High Premiums Available Through An Option Trade On This Stock | ||
Do | Fresh Video Game Data Is Positive For Roblox Stock | ||
Do | Taiwan Semi, Partner To Nvidia And Apple, Rips Higher On August Sales Growth Spike | ||
Do | AbbVie Stock Breaks Out As Its Cash Cow Lives To Fight Another Day | ||
Do | E-Commerce Demand Closed The Summer Strong. What It Means For Amazon Stock. | ||
Do | Tempus AI Surges, Flirting With A Profit-Taking Zone, On A Fresh FDA Move |